Homologous fluorescent streptococcal antibody titres equal to or greater than 400, using the patient's own blood culture isolate as the antigen, were found in the serum samples of 14 of 15 patients with endocarditis caused by viridans streptococci, three patients with enterococcal endocarditis, two patients with endocarditis caused by Str pneumoniae, and one patient with Str bovis endocarditis. In contrast, all five patients who had clinically insignificant streptococcal bacteraemias had serum fluorescent homologous antibody titres of only 100 or less. These results showed that the homologous serum fluorescent streptococcal antibody test could help to decide the clinical importance of a streptococcus which is initially isolated from only one or two of a number of inoculated blood culture bottles.
SUMMARY Serum fluorescent streptococcal antibody tests were carried out on 71 patients with clinically suspected infective endocarditis, and a final diagnosis of endocarditis was obtained in 46 patients.
A serological diagnosis of streptococcal endocarditis was obtained in 10 patients who had persistently negative blood cultures, as fluorescent streptococcal antibody titres equal to or greater than 400 were detected against at least one of four strains of streptococci used as heterologous antigens. There were no false positive fluorescent antibody results with heterologous antigens during tests on 29 patients who had either non-streptococcal endocarditis, a final diagnosis other than endocarditis, or streptococcal sepsis not associated with endocarditis. A negative result with the heterologous antibody test could not, however, exclude a diagnosis of streptococcal endocarditis as six of 11 patients with endocarditis due to Streptococcus viridans or Str bovis confirmed on blood culture had serum fluorescent antibody titres less than 400 against all the heterologous streptococcal antigens tested.
Homologous fluorescent streptococcal antibody titres equal to or greater than 400, using the patient's own blood culture isolate as the antigen, were found in the serum samples of 14 of 15 patients with endocarditis caused by viridans streptococci, three patients with enterococcal endocarditis, two patients with endocarditis caused by Str pneumoniae, and one patient with Str bovis endocarditis. In contrast, all five patients who had clinically insignificant streptococcal bacteraemias had serum fluorescent homologous antibody titres of only 100 or less. These results showed that the homologous serum fluorescent streptococcal antibody test could help to decide the clinical importance of a streptococcus which is initially isolated from only one or two of a number of inoculated blood culture bottles.
Some patients in whom a clinical diagnosis of infective endocarditis is strongly suspected have negative or equivocal blood culture results, and it has been suggested that these patients may often have undetected streptococcal endocarditis. ' Occasionally, patients' blood cultures may give negative results during the first few days of incubation of the broths and then yield growth of a slow growing streptococcus on subcultures during subsequent days or weeks from one or more bottles. It would be useful to Patients investigated included those with a possible clinical diagnosis of endocarditis in whom blood cultures were initially negative, patients who had a viridans streptococcus of uncertain clinical importance isolated from blood cultures, and a few patients who were finally shown to have non-cardiac sepsis due to viridans streptococci. When the blood culture results were equivocal a strain of streptococcus was occasionally sent through the post together with the serum sample. All the serum fluorescent streptococcal antibody tests were carried out in the Department of Clinical Microbiology at St Stephen's Hospital. Results of this test are included only where there were reasonably complete clinical as well as laboratory details available during the follow up of the patients.
SERUM FLUORESCENT STREPTOCOCCAL ANTIBODY TEST
Four positive standard reference sera, obtained from patients with endocarditis, were included with every batch of tests. The first, second, third, and fourth reference sera had high fluorescent antibody titres (between 1 in 800 and 1 in 1600) against Str mitior, Str sanguis II, Str mutans, and Str bovis I, respectively. A pooled negative control serum was also tested against each antigen.
Overnight cultures on blood agar of Str mitior (isolated from the blood of a patient with endocarditis, patient N), Str sanguis II (from a patient with endocarditis, patient L), Str mutans (from a patient with endocarditis, patient P), and Str bovis I (from a patient with endocarditis, patient C) were used as the heterologous antigens; the patient's own blood culture isolates were used for homologous antibody tests. Each culture was emulsified in buffer to give a density of between 10' and 108 organisms per millilitre using Brownes' tubes. A loopful of each antigen suspension was spread on to each well of a Teflon coated slide, dried, and flamed.
Buffer containing 180 g of potassium chloride,
8-06 g of disodium hydrogen phosphate (Na2HPOj, 6i97 g of sodium dihydrogen phosphate (NaH2POj, for use at pH 7-2. Each serum sample was initially diluted 1/50 and then in serial double dilutions up to 1/1600 in fresh buffer. Each heat fixed antigen smear was covered with diluted serum and incubated in a moist chamber at 37°C for 45 min. The serum was then washed off with buffer and the slide was immersed in fresh buffer for 5 min. Conjugate, fluorescein labelled sheep antihuman immunoglobulin (Burroughs Wellcome Ltd), diluted 1/32 in buffer, was added to cover the smear and the slide was incubated in the moist chamber for 45 min at 37°C. After incubation the slide was washed in buffer, dried, and mounted in 50% glycerol in buffer. All the slides were examined by incident light fluorescence using a Reichert-Fluovar microscope. Negative smears were checked by phase contrast microscopy to confirm the presence of streptococci in the fields examined. The titre was defined as the highest dilution of serum that gave definite fluorescence.
Results
Results ofserum fluorescent antibody test, using heterologous streptococcal antigens, in patients with blood culture positive streptococcal endocarditis Eleven patients had a diagnosis of endocarditis due to either Str viridans or Str bovis confirmed by repeated isolation of the causative organism from blood cultures (Table 1) . Positive results with serum antibody titres equal to or greater than 400 were obtained in six patients using the set of heterologous antigens. With four of these patients a more rapid serological result was available compared with the isolation of the streptococcus from blood cultures. A detailed example of the timing of serological and blood culture results in one of these four cases is given in Table 2 .
Results ofserum fluorescent antibody test using heterologous antigens in patients with evidence of streptococcal endocarditis but in whom blood cultures were negative Streptococcal endocarditis was finally detected in 10 patients by the serum fluorescent antibody test alone (Table 1 , cases 12 to 21). With most of these patients there was a firm clinical diagnosis of infective endocarditis and appropriate antibiotic treatment for streptococcal endocarditis was always given, but in a few patients the diagnosis was less certain. An example where the results of the serum fluorescent streptococcal antibody test greatly influenced the management of the patient was in a case of cerebral haemorrhage (case 2, Table 2 ). A follow up test on this patient 18 months later Results ofserum fluorescent streptococcal antibody test in patients who subsequently were given alternative diagnoses Twenty patients in whom a clinical diagnosis of endocarditis was initially suspected were subsequently considered not to have endocarditis. Most of these patients had good evidence of alternative diagnoses (Table 4) . As all 20 patients had serum fluorescent antibody titres below 400 there was no evidence of a false positive reaction in this group. 96 Shanson, Kirk, Humphrey Fluorescent antibody test for the serological diagnosis ofstreptococcal endocarditis Results ofserum fluorescent streptococcal antibody test in patients with non-cardiac sepis due to viridans streptococci There were three patients with Str millen liver abscess or empyema and one patient with Str sanguis spinal osteomyelitis, who had serum fluorescent streptococcal antibody titres between 200 and 800 against homologous antigens. The same serum samples from these patients had antibody titres equal to or less than 100 against the standard set of heterologous streptococcal antigens.
Results ofserum fluorescent streptococcal antibody test with homologous antigens in patients who had equivocal blood culture results Five patients who initially had equivocal blood culture results were rapidly shown to have high antibody titres equal to or greater than 400 against their own blood culture isolates (homologous antigens). All five patients were finally diagnosed as having streptococcal endocarditis ( Table 2 ). A high titre of class specific IgM streptococcal antibodies was also detected against heterologous antigen in an early serum sample from case 2. This suggests that IgM specific streptococcal antibody tests may be useful to help confirm current active infection when early serum samples are available.
The results of the study also clearly show that a negative result obtained with the serum fluorescent streptococcal antibody test with heterologous antigens does not exclude endocarditis due to viridans streptococci as there were frequent false negative reactions. These false negative reactions could sometimes be explained by infection due to strains of viridans streptococci which were not included in the set of indicator strains such as Str milleri and Str salivarius. Furthermore, some patients with infective endocarditis caused by Str mutans and Str mitior developed high homologous antibody titres but failed to react serologically with the indicator strains of Str mitior or Str mutans used in the study. One other report of the use of a serum fluorescent streptococcal antibody test for the serological diagnosis of streptococcal endocarditis also found individual strain variability in reactions with sera from patients with Str viridans endocarditis, and no indicator strain of Str mitior was found particularly suitable as a heterologous antigen.4 In our experience the one strain that reacted more than any other strain with sera from patients with endocarditis was the Str mitior strain from patient N. The Str sanguis II strain used in our study had poor reactivity and might usefully be replaced by another strain in the future. The Str mutans strain also showed poor reactivity not only with sera from patients with Str mitior endocarditis but also with the one case of Str mutans endocarditis investigated. Str milleri endocarditis has been reported more frequently in the past few years and it may be worthwhile to include a heterologous Str milleri antigen for future clinical tests. Although Str bovis is not strictly a viridans streptococcus but a Lancefield group D streptococcus, it was interesting that some patients in the blood 98 culture negative group gave strong serological reactions with Str bovis and either Str mitior or Str mutans. There are probably some antigenic cross reactions between some strains of viridans streptococci and Str bovis.
So far our clinical evaluation suggests that the serum fluorescent streptococcal antibody test using the current set of heterologous antigens is specific for detecting endocarditis due to Str viridans or Str bovis but that its sensitivity needs to be further improved. The indicator strains used in this study were mainly selected as heterologous antigens on an empirical basis since three of the four strains used had been studied previously.2 Theoretical knowledge about which cell wall antigens react with antibodies in this serum fluorescent antibody test is lacking. Therefore, the optimal adjustment of the panel of heterologous antigens to improve the sensitivity of the test must depend largely on clinical trial and error assessments. Information about some other investigations such as circulating immune complexes was not usually available when serum samples for heterologous antibody tests were received from other hospitals. It is possible that certain patients may have had negative fluorescent antibody test results because of antigen-antibody complexes, rather than the use of inappropriate antigens. This possibility deserves investigation and tests to detect streptococcal antigen as well as antibody may also need to be developed.
The serum fluorescent streptococcal antibody test results using homologous antigens from patients with equivocal blood culture results has shown that this test is simple and useful diagnostically as positive results were nearly always associated with subsequent confirmation of endocarditis. Negative results also usually indicated a clinically insignificant Shanson, Kirk, Humphrey streptococcal bacteraemia. In the few patients who were monitored over a long period after the treatment of streptococcal endocarditis it was apparent that the homologetis antibody titre took at least 18 months to two years to fall from original titres of 800 to 1600 to subsequent final titres of less than 100 against homologous antigens. This test is therefore of little practical value for any monitoring of treatment
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